Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients

被引:3
|
作者
Chen, Min [1 ,2 ]
Chen, Ting [1 ]
机构
[1] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu, Peoples R China
[2] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu 215500, Peoples R China
关键词
early onset colorectal cancer; conditional survival; nomogram; overall survival; cancer-specific survival;
D O I
10.1093/jjco/hyac169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to assess conditional survival in stages I-III early onset colorectal cancer patients and to create nomograms predicting the conditional overall survival and cancer-specific survival after surgery. Methods A total of 7058 patients who underwent surgical resection of early onset colorectal cancer were identified from surveillance, epidemiology and end results database. The formula used for conditional survival calculation was conditional survival((x|y)) = S(x + y)/S-(x), where S-(x) represents the survival at x years. Conditional survival nomograms were then developed to predict the 5-year conditional overall survival and cancer-specific survival. Results The 5-year overall survival and cancer-specific survival after surgery increases gradually with additional survival time. Race, tumour site, grade, histology, T stage, N stage, lymph node ratio, preoperative carcinoma embryonic antigen level and perineural invasion status were independent predictors of cancer-specific survival, while age and sex were another two independent risk factors for overall survival. The nomograms based on these factors were successfully developed to predict 5-year overall survival and cancer-specific survival given 1-4 years already survived. Conclusion The probability of achieving postoperative 5-year overall survival and cancer-specific survival for early onset colorectal cancer increases gradually with additional time survived. The developed nomograms are fairly valuable and informative in facilitating clinical treatment and follow-up schemes. No previous studies have attempted to analyse the conditional survival for early onset colorectal cancer patients. We successfully developed nomograms to predict conditional survival with considerable prognostic accuracy for these patients.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [1] Survival nomograms for stage III colorectal cancer
    Li, Chenglong
    Pei, Qian
    Zhu, Hong
    Tan, Fengbo
    Zhou, Zhongyi
    Zhou, Yuan
    Li, Yuqiang
    Pei, Haiping
    MEDICINE, 2018, 97 (49)
  • [2] A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
    Spillane, Susan
    Bennett, Kathleen
    Sharp, Linda
    Barron, Thomas I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (08) : 1364 - 1373
  • [3] Impact of rural and remoteness on overall survival in Australian patients with stage I-III colorectal cancer
    Mullany, Christina M.
    Rose, June
    Ranson, Marie
    Brungs, Daniel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 99 - 99
  • [4] Survival after recurrence of stage I-III breast, colorectal, or lung cancer
    Hassett, Michael J.
    Uno, Hajime
    Cronin, Angel M.
    Carroll, Nikki M.
    Hornbrook, Mark C.
    Fishman, Paul
    Ritzwoller, Debra P.
    CANCER EPIDEMIOLOGY, 2017, 49 : 186 - 194
  • [5] The gut microbiome is associated with disease-free survival in stage I-III colorectal cancer patients
    Byrd, Doratha A.
    Damerell, Victoria
    Gomez Morales, Maria F.
    Hogue, Stephanie R.
    Lin, Tengda
    Ose, Jennifer
    Himbert, Caroline
    Ilozumba, Mmadili N.
    Kahlert, Christoph
    Shibata, David
    Toriola, Adetunji T.
    Li, Christopher I.
    Figueiredo, Jane
    Stephens, W. Zac
    Warby, Christy A.
    Hardikar, Sheetal
    Siegel, Erin M.
    Round, June
    Ulrich, Cornelia M.
    Gigic, Biljana
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [6] Post-operative Aspirin Use and Colorectal Cancer-specific Survival in Patients with Stage I-III Colorectal Cancer
    Goh, Hin Hock
    Leong, Wei Qi
    Chew, Min Hoe
    Pan, Yihui Summer
    Tony, Lim Kiat Hon
    Chew, Lita
    Tan, Iain Bee Huat
    Toh, Han Chong
    Tang, Choong Leong
    Fu, Wan Pei Cherylin
    Chia, Whay Kuang
    ANTICANCER RESEARCH, 2014, 34 (12) : 7407 - 7414
  • [7] The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I-III colorectal cancer
    Xie, Hailun
    Wei, Lishuang
    Liu, Mingxiang
    Liang, Yanren
    Wang, Qiwen
    Tang, Shuangyi
    Gan, Jialiang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Association of a newly developed Cancer Cachexia Score with survival in Stage I-III colorectal cancer
    Takano, Yasuhiro
    Kodera, Keita
    Tsukihara, Shu
    Takahashi, Sumika
    Yasunobu, Kobayashi
    Kanno, Hironori
    Ishiyama, Satoshi
    Saito, Ryota
    Hanyu, Nobuyoshi
    Eto, Ken
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [9] The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer
    Brown, Justin C.
    Caan, Bette J.
    Prado, Carla M.
    Feliciano, Elizabeth M. Cespedes
    Xiao, Jingjie
    Kroenke, Candyce H.
    Meyerhardt, Jeffrey A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (04): : 377 - 383
  • [10] Impact of Preoperative Nutritional Status on Long-term Survival in Patients With Stage I-III Colorectal Cancer
    Shibutani, Masatsune
    Kashiwagi, Shinichiro
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Kasashima, Hiroaki
    Maeda, Kiyoshi
    IN VIVO, 2023, 37 (04): : 1765 - 1774